Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Recruiting · NCT07321912 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma | Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2026-10-06 | NCT07321912 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Milton S. Hershey Medical Center | 79 |
| USWM, LLC (dba US WorldMeds) | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Penn State Milton S. Hershey Medical Center and Children's Hospital | Hershey | United States | 11 |
| Randall Children's Hospital | Portland | United States | 7 |
| St. Joseph's Children's Hospital | Tampa | United States | 7 |